FML-S Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fml-s, and what generic alternatives are available?
Fml-s is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in FML-S is fluorometholone; sulfacetamide sodium. There are five drug master file entries for this compound. Additional details are available on the fluorometholone; sulfacetamide sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FML-S?
- What are the global sales for FML-S?
- What is Average Wholesale Price for FML-S?
Summary for FML-S
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Patent Applications: | 5,215 |
| DailyMed Link: | FML-S at DailyMed |
US Patents and Regulatory Information for FML-S
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | FML-S | fluorometholone; sulfacetamide sodium | SUSPENSION/DROPS;OPHTHALMIC | 019525-001 | Sep 29, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
